PMC:3359311 / 236-347 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T364	52-70	P01584	denotes	Interleukin-1 beta
T365	72-77	P01584	denotes	IL-1β

Id	Subject	Object	Predicate	Lexical cue
T40	52-70	Protein	denotes	Interleukin-1 beta
T41	72-77	Protein	denotes	IL-1β
R25	T41	T40	equivalentTo	IL-1β,Interleukin-1 beta

Id	Subject	Object	Predicate	Lexical cue
T802	52-70	Protein	denotes	Interleukin-1 beta
T803	72-77	Protein	denotes	IL-1β
T804	101-109	Positive_regulation	denotes	mediator
T805	101-109	Positive_regulation	denotes	mediator
R667	T802	T804	themeOf	Interleukin-1 beta,mediator
R668	T803	T805	themeOf	IL-1β,mediator

Id	Subject	Object	Predicate	Lexical cue
T770	52-70	Protein	denotes	Interleukin-1 beta
T771	72-77	Protein	denotes	IL-1β
R647	T771	T770	equivalentTo	IL-1β,Interleukin-1 beta

Id	Subject	Object	Predicate	Lexical cue
T694	30-45	http://purl.bioontology.org/ontology/ICD10/E84	denotes	cystic fibrosis
T695	30-45	http://purl.bioontology.org/ontology/ICD10/E84.9	denotes	cystic fibrosis

Id	Subject	Object	Predicate	Lexical cue
T681	52-70	http://purl.obolibrary.org/obo/GO_0050720	denotes	Interleukin-1 beta
T682	52-70	http://purl.obolibrary.org/obo/GO_0050702	denotes	Interleukin-1 beta
T683	64-74	http://purl.obolibrary.org/obo/GO_0032611	denotes	1 beta (IL

Id	Subject	Object	Predicate	Lexical cue
T403	0-3	CC	denotes	and
T404	4-11	NN	denotes	outcome
T405	12-15	IN	denotes	for
T406	16-24	NNS	denotes	patients
T407	25-29	IN	denotes	with
T408	30-36	JJ	denotes	cystic
T409	37-45	NN	denotes	fibrosis
T410	46-47	-LRB-	denotes	(
T411	47-49	NNP	denotes	CF
T412	49-50	-RRB-	denotes	)
T413	50-51	.	denotes	.
T414	52-65	NN	denotes	Interleukin-1
T415	66-70	NN	denotes	beta
T416	71-72	-LRB-	denotes	(
T417	72-77	NN	denotes	IL-1β
T418	77-78	-RRB-	denotes	)
T419	79-81	VBZ	denotes	is
T420	82-83	DT	denotes	a
T421	84-87	JJ	denotes	key
T422	88-100	JJ	denotes	inflammatory
T423	101-109	NN	denotes	mediator
T424	109-110	.	denotes	.
R344	T406	T405	pobj	patients,for
R345	T407	T406	prep	with,patients
R346	T408	T409	compound	cystic,fibrosis
R347	T409	T407	pobj	fibrosis,with
R348	T410	T411	punct	(,CF
R349	T411	T409	appos	CF,fibrosis
R352	T414	T415	compound	Interleukin-1,beta
R353	T415	T419	nsubj	beta,is
R354	T416	T417	punct	(,IL-1β
R355	T417	T415	appos	IL-1β,beta
R356	T418	T417	punct	),IL-1β
R357	T419	T419	ROOT	is,is
R358	T420	T423	det	a,mediator
R359	T421	T423	amod	key,mediator
R360	T422	T423	amod	inflammatory,mediator
R361	T423	T419	attr	mediator,is
R362	T424	T419	punct	.,is

Id	Subject	Object	Predicate	Lexical cue
T114	0-3	CC	denotes	and
T115	4-11	NN	denotes	outcome
T116	12-15	IN	denotes	for
T117	16-24	NN	denotes	patients
T118	25-29	IN	denotes	with
T119	30-36	JJ	denotes	cystic
T120	37-45	NN	denotes	fibrosis
T121	46-47	-LRB-	denotes	(
T122	47-49	NN	denotes	CF
T123	49-50	-RRB-	denotes	)
T124	52-65	NN	denotes	Interleukin-1
T125	66-70	NN	denotes	beta
T126	71-72	-LRB-	denotes	(
T127	72-77	NN	denotes	IL-1β
T128	77-78	-RRB-	denotes	)
T129	79-81	VB	denotes	is
T130	82-83	DT	denotes	a
T131	84-87	JJ	denotes	key
T132	88-100	JJ	denotes	inflammatory
T133	101-109	NN	denotes	mediator
R70	T115	T114	arg2Of	outcome,and
R71	T117	T116	arg2Of	patients,for
R72	T117	T118	arg1Of	patients,with
R73	T120	T118	arg2Of	fibrosis,with
R74	T120	T119	arg1Of	fibrosis,cystic
R75	T120	T121	arg1Of	fibrosis,(
R76	T122	T121	arg2Of	CF,(
R77	T123	T121	arg3Of	),(
R78	T125	T124	arg1Of	beta,Interleukin-1
R79	T125	T126	arg1Of	beta,(
R80	T125	T129	arg1Of	beta,is
R81	T127	T126	arg2Of	IL-1β,(
R82	T128	T126	arg3Of	),(
R83	T133	T129	arg2Of	mediator,is
R84	T133	T130	arg1Of	mediator,a
R85	T133	T131	arg1Of	mediator,key
R86	T133	T132	arg1Of	mediator,inflammatory

Id	Subject	Object	Predicate	Lexical cue
T75	52-110	Sentence	denotes	Interleukin-1 beta (IL-1β) is a key inflammatory mediator.
T5	52-110	Sentence	denotes	Interleukin-1 beta (IL-1β) is a key inflammatory mediator.